chr17-44375719-G-C
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 9P and 0B. PM3PM4PP4_StrongPM2_Supporting
This summary comes from the ClinGen Evidence Repository: The NM_000419.4:c.2602-3C>G variant is a splice region variant that is predicted to result in abnormal splicing and is shown to skip exon 26 in RNA studies from a patient (PMID:1317725), resulting in an in-frame deletion of Val868 to Val909 (3.9% of the protein; PM4). It occurs at a low frequency in gnomADv2.1.1 with a MAF of 0.00006523 in the East Asian population (PM2_supporting). At least 3 compound heterozygous probands are reported in the literature, with the other variants being Leu973AlafsTer63, Leu214Pro, and Ala777Asp (PMID:15748238, PMID:27696190, PMID:29675921; PM3). In summary, based on the available evidence at this time, the c.2602-3C>G variant is classified as likely pathogenic. GT-specific criteria applied: PM2_supporting, PM3, PM4, PP4_strong. LINK:https://erepo.genome.network/evrepo/ui/classification/CA10575472/MONDO:0010119/011
Frequency
Consequence
ENST00000262407.6 splice_region, splice_polypyrimidine_tract, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ITGA2B | NM_000419.5 | c.2602-3C>G | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ENST00000262407.6 | NP_000410.2 | |||
ITGA2B | XM_011524749.2 | c.2755-3C>G | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | XP_011523051.2 | ||||
ITGA2B | XM_011524750.2 | c.2755-3C>G | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | XP_011523052.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ITGA2B | ENST00000262407.6 | c.2602-3C>G | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_000419.5 | ENSP00000262407 | P1 | |||
ITGA2B | ENST00000587295.5 | c.253+114C>G | intron_variant | 3 | ENSP00000467269 | |||||
ITGA2B | ENST00000648408.1 | c.2033-3C>G | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ENSP00000498119 | ||||||
ITGA2B | ENST00000592462.5 | n.1397-3C>G | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152070Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000551 AC: 1AN: 181340Hom.: 0 AF XY: 0.0000103 AC XY: 1AN XY: 97246
GnomAD4 exome AF: 0.00000563 AC: 8AN: 1420694Hom.: 0 Cov.: 34 AF XY: 0.00000569 AC XY: 4AN XY: 703150
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152070Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74288
ClinVar
Submissions by phenotype
Glanzmann thrombasthenia Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 26, 2022 | Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Studies have shown that this variant results in skipping of exon 26, but is expected to preserve the integrity of the reading-frame (PMID: 1317725). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 2893). This variant has been observed in individual(s) with Glanzmann thrombasthenia (PMID: 1317725, 29675921). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is present in population databases (no rsID available, gnomAD 0.007%). This sequence change falls in intron 25 of the ITGA2B gene. It does not directly change the encoded amino acid sequence of the ITGA2B protein. RNA analysis indicates that this variant induces altered splicing and likely results in a shortened protein product. - |
Likely pathogenic, reviewed by expert panel | curation | ClinGen Platelet Disorders Variant Curation Expert Panel, ClinGen | Sep 07, 2023 | The NM_000419.4:c.2602-3C>G variant is a splice region variant that is predicted to result in abnormal splicing and is shown to skip exon 26 in RNA studies from a patient (PMID: 1317725), resulting in an in-frame deletion of Val868 to Val909 (3.9% of the protein; PM4). It occurs at a low frequency in gnomADv2.1.1 with a MAF of 0.00006523 in the East Asian population (PM2_supporting). At least 3 compound heterozygous probands are reported in the literature, with the other variants being Leu973AlafsTer63, Leu214Pro, and Ala777Asp (PMID: 15748238, PMID: 27696190, PMID: 29675921; PM3). In summary, based on the available evidence at this time, the c.2602-3C>G variant is classified as likely pathogenic. GT-specific criteria applied: PM2_supporting, PM3, PM4, PP4_strong. - |
Glanzmann thrombasthenia 1 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jun 15, 1992 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at